Exposure to the phthalate metabolite MEHP impacts survival and growth of human ovarian follicles in vitro.

Kiriaki Papaikonomou, Cecilia Lindskog, Anastasios Damdimopoulos, Pauliina Damdimopoulou, Karin Pettersson, Mikael Pedersen, Eleftheria Maria Panagiotou, Tianyi Li, Elisabeth Moussaud-Lamodière, Filipa Lebre, Catarina Arnelo, Ernesto Alfaro-Moreno, Terje Svingen

Journal: Toxicology 2024;505():153815

PMID: 38685446

Abstract

Phthalates are found in everyday items like plastics and personal care products. There is an increasing concern that continuous exposure can adversely affect female fertility. However, experimental data are lacking to establish causal links between exposure and disease in humans. To address this gap, we tested the effects of a common phthalate metabolite, mono-(2-ethylhexyl) phthalate (MEHP), on adult human ovaries in vitro using an epidemiologically determined human-relevant concentration range (2.05 nM - 20.51 mM). Histomorphological assessments, steroid and cytokine measurements were performed on human ovarian tissue exposed to MEHP for 7 days in vitro. Cell viability and gene expression profile were investigated following 7 days of MEHP exposure using the human granulosa cancer cell lines KGN, and COV434, the germline tumor cell line PA-1, and human ovarian primary cells. Selected differentially expressed genes (DEGs) were validated by RT-qPCR and immunofluorescence in human ovarian tissue. MEHP exposure reduced follicular growth (20.51 nM) and increased follicular degeneration (20.51 mM) in ovarian tissue, while not affecting steroid and cytokine production. Out of the 691 unique DEGs identified across all the cell types and concentrations, CSRP2 involved in cytoskeleton organization and YWHAE as well as CTNNB1 involved in the Hippo pathway, were chosen for further validation. CSRP2 was upregulated and CTNNB1 downregulated in both ovarian tissue and cells, whereas YWHAE was downregulated in cells only. In summary, one-week MEHP exposure of human ovarian tissue can perturb the development and survival of human follicles through mechanisms likely involving dysregulation of cytoskeleton organization and Hippo pathway.

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Address: Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm 14186, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm 171 77, Sweden. Electronic address: [email protected].; Bioinformatics and Expression Analysis Core Facility, Karolinska Institutet, Stockholm 14186, Sweden.; Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm 14186, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm 171 77, Sweden.; National Food Institute, Technical University of Denmark, Kgs. Lyngby DK-2800, Denmark.; Nanosafety Group, International Iberian Nanotechnology Laboratory, Braga, Portugal.; Department of Pregnancy and Delivery, Karolinska University Hospital, Stockholm, Sweden.; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm 171 77, Sweden.; Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala, Sweden.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.